AstraZeneca's Enhertu receives Indian regulatory approval for first-line HER2-positive breast cancer treatment, offering a new therapeutic option.
pharma manufacturing
India's drug pricing authority is reviewing essential cancer drug prices, including carboplatin and cisplatin, due to escalating...
Serum Institute of India partners with Oxford University to produce a new Ebola vaccine, backed by $8.6M...
Novartis' experimental actinium-based drug shows promising anti-tumor activity in prostate cancer patients, with higher response rates in...
Cipla aims for 40-50 global product filings in three years, focusing on innovation, complex generics, and biosimilars...
Zydus Therapeutics' saroglitazar receives US FDA priority review for primary biliary cholangitis, a rare liver disease. Potential...
Wockhardt's indigenously developed antibiotic, Zaynich, receives CDSCO approval for treating complicated urinary tract infections in adults, marking...
Mankind Pharma's Q4 profit surged 30%, driven by strong chronic therapy demand and consumer healthcare revival. Domestic...
India's Patent Office denies AbbVie's secondary patent bid for Hepatitis C drug Maviret, ensuring continued access to...
Dr Reddy's introduces generic Semaglutide in Canada, enhancing access to vital diabetes and weight management therapies. A...